QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
NASDAQ:BIOS

BioPlus Acquisition (BIOS) Stock Forecast, Price & News

$10.63
0.00 (0.00%)
(As of 06/8/2023 ET)
Compare
Today's Range
$10.60
$10.64
50-Day Range
$10.44
$10.63
52-Week Range
$9.91
$10.97
Volume
1,196 shs
Average Volume
190,101 shs
Market Capitalization
$311.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

BIOS stock logo

About BioPlus Acquisition (NASDAQ:BIOS) Stock

BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.

Receive BIOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioPlus Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BIOS Stock News Headlines

BIOS BioPlus Acquisition Corp.
“One-Stock Millionaire” IGNORES 99.9% of the Market
During the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.
BioPlus Acquisition Corp. (NASDAQ:BIOS) Short Interest Update
BioPlus Acquisition Corp - Ordinary Shares - Class A
BioPlus Acquisition Corp. Cl A
“One-Stock Millionaire” IGNORES 99.9% of the Market
During the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.
BioPlus Acquisition Corp. (BIOS)
BioPlus Acquisition Corp (BIOS)
BioPlus Acquisition Corp
See More Headlines

BIOS Price History

BIOS Company Calendar

Today
6/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:BIOS
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
22,686,000
Market Cap
$311.54 million
Optionable
Not Optionable
Beta
0.01

Key Executives

  • Mr. Jonathan M. N. Rigby MBA (Age 55)
    Chairman & Chief Bus. Officer
  • Mr. Ross Haghighat (Age 59)
    CEO, CFO & Director













BIOS Stock - Frequently Asked Questions

How have BIOS shares performed in 2023?

BioPlus Acquisition's stock was trading at $10.22 at the beginning of 2023. Since then, BIOS stock has increased by 4.0% and is now trading at $10.6290.
View the best growth stocks for 2023 here
.

Are investors shorting BioPlus Acquisition?

BioPlus Acquisition saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 2,500 shares, a decrease of 79.3% from the April 30th total of 12,100 shares. Based on an average daily trading volume, of 150,300 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the company's stock are sold short.
View BioPlus Acquisition's Short Interest
.

What ETFs hold BioPlus Acquisition's stock?

ETFs with the largest weight of BioPlus Acquisition (NASDAQ:BIOS) stock in their portfolio include Horizon Kinetics SPAC Active ETF (SPAQ) and Robinson Alternative Yield Pre-Merger SPAC ETF (SPAX).CrossingBridge Pre-Merger SPAC ETF (SPC).

When did BioPlus Acquisition IPO?

(BIOS) raised $180 million in an initial public offering (IPO) on Friday, December 3rd 2021. The company issued 18,000,000 shares at a price of $10.00 per share. Cantor acted as the underwriter for the IPO.

What is BioPlus Acquisition's stock symbol?

BioPlus Acquisition trades on the NASDAQ under the ticker symbol "BIOS."

Who are BioPlus Acquisition's major shareholders?

BioPlus Acquisition's stock is owned by many different retail and institutional investors. Top institutional shareholders include Picton Mahoney Asset Management (3.92%), Boothbay Fund Management LLC (2.67%), First Trust Capital Management L.P. (2.39%), Berkley W R Corp (2.26%), Periscope Capital Inc. (1.63%) and Shaolin Capital Management LLC (1.36%).

How do I buy shares of BioPlus Acquisition?

Shares of BIOS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BioPlus Acquisition's stock price today?

One share of BIOS stock can currently be purchased for approximately $10.63.

How much money does BioPlus Acquisition make?

BioPlus Acquisition (NASDAQ:BIOS) has a market capitalization of $311.54 million.

How can I contact BioPlus Acquisition?

BioPlus Acquisition's mailing address is 260 MADISON AVENUE SUITE 800, NEW YORK NY, 10016. The official website for the company is bioplusspac.com. The company can be reached via phone at 212-287-4092.

This page (NASDAQ:BIOS) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -